Catalyxx: Funding, Investors & Team (Sep 2026)
Catalyxx is an innovative company in the green technology sector that is revolutionizing the chemical industry by replacing fossil-based feedstocks. Their patented catalytic chemistry technology converts bioethanol into valuable intermediate chemicals, such as butanol, hexanol, octanol, and decanol. The proven technology, demonstrated at a Demo Plant, is scalable and ready for industrial deployment. Additionally, it is carbon negative, reducing 3.5kg of CO2 for every kg of chemical produced. Catalyxx aims to become a global leader in catalytic chemistry, enabling the substitution of petrochemical products derived from crude oil with those made from sustainable and bio-based sources.
Catalyxx has raised $9.1M across 2 funding rounds on record, the most recent an undisclosed round of $3.4M announced in May 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Catalyxx Company Profile and Key Stats
Latest funding round on record: May 2025.
Catalyxx Funding Rounds
Catalyxx raised $5.7M in a Series A announced in Nov 2024.
6 months later, an undisclosed round of $3.4M was announced in May 2025.
Catalyxx Founders and Leadership Team
Contact details for the Catalyxx team: 1 of 1 has an email address on file.
Start 14-day free trial →Catalyxx Funding Compared to Other Biotechnology Startups
Catalyxx's latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Catalyxx in Biotechnology and Chesterfield
Companies Similar to Catalyxx
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Catalyxx Funding FAQs
What does Catalyxx do?
Catalyxx is an innovative company in the green technology sector that is revolutionizing the chemical industry by replacing fossil-based feedstocks. Their patented catalytic chemistry technology converts bioethanol into valuable intermediate chemicals, such as butanol, hexanol, octanol, and decanol. The proven technology, demonstrated at a Demo Plant, is scalable and ready for industrial deployment. Additionally, it is carbon negative, reducing 3.5kg of CO2 for every kg of chemical produced. Catalyxx aims to become a global leader in catalytic chemistry, enabling the substitution of petrochemical products derived from crude oil with those made from sustainable and bio-based sources.
How much funding has Catalyxx raised?
Catalyxx has raised $9.1M across 2 rounds on record. The most recent is an undisclosed round of $3.4M announced in May 2025.
When did Catalyxx last raise funding?
Catalyxx's most recent funding round on record is an undisclosed round of $3.4M, announced in May 2025.
Who founded Catalyxx?
FundedIQ lists Joaquin Alarcon De La Lastra Romero (Founder) at Catalyxx.
Where is Catalyxx headquartered?
Catalyxx is based in Chesterfield, Missouri, United States.
How many employees does Catalyxx have?
Catalyxx is in the 11-50 employee band.
How does Catalyxx's funding compare to other Biotechnology startups?
Catalyxx's latest round of $3.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Catalyxx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Catalyxx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.